Description
AVMOL IBP Suspension 100ml – Product Profile for Monark Biocare
Introduction
AVMOL IBP Suspension 100ml is a powerful, fast-acting combination pediatric formulation from Monark Biocare that offers dual relief from fever and pain. This well-balanced antipyretic and anti-inflammatory suspension contains Ibuprofen and Paracetamol (Acetaminophen), designed to effectively manage high fever, inflammation, and body pain in children. Manufactured under WHO-GMP certified facilities, AVMOL IBP is trusted by healthcare professionals across India for its superior efficacy, safety, and palatability.
Composition (Per 5 ml):
- Ibuprofen IP: 100 mg
- Paracetamol IP: 162.5 mg
Pack Size: 100 ml bottle with measuring cap
Pharmacological Class:
- Non-Steroidal Anti-inflammatory Drug (NSAID) and Analgesic-Antipyretic combination
Therapeutic Indications
AVMOL IBP Suspension is indicated for the following pediatric conditions:
-
Fever (low-grade and high-grade)
-
Post-vaccination fever and pain
-
Muscular pain
-
Teething pain
-
Earaches
-
Headaches
-
Inflammatory pain associated with sore throat, cold, and flu
Mechanism of Action
-
Ibuprofen: A non-steroidal anti-inflammatory drug (NSAID), ibuprofen works by inhibiting cyclooxygenase (COX-1 and COX-2) enzymes, thereby blocking the synthesis of prostaglandins—chemicals responsible for pain, fever, and inflammation.
-
Paracetamol: Acts centrally by inhibiting prostaglandin synthesis in the brain, reducing fever and providing mild to moderate pain relief.
Together, they provide a synergistic effect for faster and longer relief.
Dosage & Administration
Dosage must be prescribed by a pediatrician or physician based on the child’s age and weight.
Typical dosage (as general guidance):
-
6 months to 1 year: 2.5 ml to 5 ml
-
1–3 years: 5 ml to 7.5 ml
-
4–6 years: 7.5 ml to 10 ml
-
7–12 years: 10 ml to 15 ml
Directions for Use:
-
Shake the bottle well before each use
-
Administer using the provided measuring cap
-
Do not exceed 4 doses in 24 hours
-
Maintain at least a 6-hour gap between doses
Advantages of AVMOL IBP 100ml
-
Dual-action formula for enhanced effectiveness
-
Fast onset of action for high fever and body pain
-
Longer duration of relief compared to single-ingredient syrups
-
Pediatric-friendly flavor for better compliance
-
Well-tolerated with minimal side effects
Why Doctors Prefer AVMOL IBP
-
Balanced formulation of Ibuprofen and Paracetamol
-
Suitable for a broad range of pediatric illnesses
-
Effective in reducing both pain and inflammation
-
Clear dosing instructions and safe usage
-
Trusted by pediatricians and recommended across medical practices
Safety & Side Effects
AVMOL IBP is safe when used as directed. However, mild side effects may include:
-
Stomach discomfort
-
Nausea or vomiting
-
Skin rash (rare)
-
Allergic reactions (in very rare cases)
Important Precautions:
-
Avoid if the child has a history of gastric ulcers or kidney issues
-
Do not administer along with other NSAIDs or paracetamol-based medications
-
Always follow pediatric dosing strictly
Contraindications:
-
Known hypersensitivity to Ibuprofen or Paracetamol
-
Severe hepatic or renal impairment
-
History of gastrointestinal bleeding or peptic ulcers
Storage Guidelines
-
Store in a cool, dry place below 25°C
-
Protect from direct sunlight and moisture
-
Keep out of reach of children
Monark Biocare’s Commitment to Quality
AVMOL IBP 100ml is manufactured in state-of-the-art WHO-GMP certified facilities. Monark Biocare ensures:
-
Rigorous quality control at every production stage
-
Batch-level testing for purity and potency
-
Hygienic packaging and labeling for long shelf life
Franchise & Distribution Opportunity
AVMOL IBP presents an excellent business opportunity for PCD Pharma Franchise seekers across India. Monark Biocare offers:
-
Monopoly-based franchise rights
-
Quick delivery and stock availability
-
Promotional inputs like MR bags, literature, visual aids
-
Attractive profit margins and competitive pricing
-
Medical and marketing training support
Ideal for:
-
Pediatricians
-
Childcare clinics
-
General medicine practitioners
-
Retail pharmacies
-
Pediatric hospitals and nursing homes
Market Potential of AVMOL IBP
With the increasing incidence of viral fevers, flu, and inflammatory conditions in children due to climate changes and school crowding, there is a growing need for effective combination therapy.
AVMOL IBP fits this need perfectly by:
-
Offering dual relief with one medication
-
Reducing medication frequency
-
Enhancing pediatric patient recovery
Marketing Edge with Monark Biocare
AVMOL IBP is not just another fever syrup—it’s a brand supported by:
-
Nationwide doctor recommendations
-
High recall value among parents
-
Professional packaging that inspires trust
-
Continuous brand-building initiatives
